Jump to main content
Jump to site search


Tumor immune microenvironment modulation-based drug delivery strategies for cancer therapy

Abstract

The past years witnessed the promising clinical feedback of anti-cancer immunotherapies, which have become one of the hot topics, although limited with poor delivery kinetics, narrow patient response profiles, or systemic side effects. To the best of our knowledge, the development of cancer is highly associated with the immune system, especially the tumor immune microenvironment (TIME). Based on the comprehensive understanding of the complexity and diversity of TIME, drug delivery strategies focused on the modulation of TIME could be of great significance for directing and improving cancer immunotherapy. This review will highlight the TIME modulation in cancer immunotherapy and summarize the versatile TIME modulation-based cancer immunetherapeutic strategies, medicative principles and accessory biotechniques for further clinical transformation. Remarkably, the recent advances of cancer immunotherapeutic drug delivery systems and future prospects of the TIME modulation-based drug delivery systems for much more controlled and precise cancer immunotherapy will be emphatically discussed.

Back to tab navigation

Publication details

The article was received on 19 Sep 2019, accepted on 25 Nov 2019 and first published on 26 Nov 2019


Article type: Review Article
DOI: 10.1039/C9NR08086D
Nanoscale, 2019, Accepted Manuscript

  •   Request permissions

    Tumor immune microenvironment modulation-based drug delivery strategies for cancer therapy

    S. Han, K. Huang, Z. Gu and J. Wu, Nanoscale, 2019, Accepted Manuscript , DOI: 10.1039/C9NR08086D

Search articles by author

Spotlight

Advertisements